Clinical Trial Update: Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on a new critical pathway for treating acute bacterial skin and skin structure infections (ABSSSI) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infection

Drugs mentioned

• Allergan

Snippet

Sponsor: Allergan | Conditions: Bacterial Infections, Acute Bacterial Skin and Skin Structure Infection | Phase 4 | Status: COMPLETED | Results posted: 2020-01-18